Mogamulizumab, a humanized mAb against C-C chemokine receptor 4 for the potential treatment of T-cell lymphomas and asthma.
Year: 2010
Type: article
Source: PubMed
Author: Sabina A Antoniu
Institution: Grigore T. Popa University of Medicine and Pharmacy
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2432602140